Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV001655662 | SCV001157439 | benign | not provided | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001655662 | SCV001863593 | benign | not provided | 2019-02-21 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001664601 | SCV001876063 | benign | Capillary malformation-arteriovenous malformation 2 | 2021-07-30 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001664600 | SCV001876064 | benign | Lymphatic malformation 7 | 2021-07-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001655662 | SCV002407930 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002409332 | SCV002722495 | benign | Cardiovascular phenotype | 2018-12-04 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV001655662 | SCV005268182 | benign | not provided | criteria provided, single submitter | not provided |